This Website is for European Healthcare Professionals Only

For Lacrifill US Click here

to learn more, use the form below​

Dry eye treatment, reinvented.

Revolutionise your approach to dry eye management with
Lacrifill® Canalicular Gel for lacrimal occlusion.

Lacrifill at ESCRS 2025

Lacrifill was showcased during the latest ESCRS Conference in Copenhagen where two renowned experts, Prof. Benitez del Castillo (Spain) and Dr. Donnenfeld (USA) discussed the importance of managing dry eye in surgery patients and shared the clinical evidence and their experience with Lacrifill.
View the session’s highlights here.

To access the full video, please register your interest with the form below.

*mandatory fields

By submitting this form you agree to receive promotional communications from Nordic Pharma and be contacted by a Nordic Pharma representative about relevant Nordic Pharma products.

We take your data privacy seriously. To learn more about how we store your data, view our Privacy Policy.

Request more information on Lacrifill® Canalicular Gel

If you would like to receive further information about Lacrifill®, be trained, receive samples or place an order, please fill out the below form.
Find out more
The new hyaluronic acid canalicular gel that delivers up to 6 months of dry eye relief with a single treatment, by maintaining natural tears on the ocular surface1,2

Lacrifill® blocks tear drainage by occlusion of the canaliculus for up to 6 months, and can be re-administered after 6 months.

Lacrifill® is intended for use in adult patients experiencing dry eye symptoms.

Find out more

Why choose Lacrifill® Canalicular Gel?

Demonstrated long-lasting efficacy

    • Improves the signs and symptoms of dry eye1
    • Improves the ocular surface1
    • Is effective for 6 months1

Easy administration and comfortable to wear1

    • One-size-fits all: no need for individual sizing2
file_download Download Instructions for Use

How to use Lacrifill® Canalicular Gel

Lacrifill® comes in a pre-filled syringe with 0.6ml of gel, appropriately dosed to treat one patient.

Lacrifill® can be administered by appropriately trained healthcare professionals such as ophthalmologists and optometrists in a standard practice setting.

To receive further information on Lacrifill® administration and training please register your interest below.

Watch the video below to learn how to administer Lacrifill®:

To report an adverse event or any other incidents regarding Lacrifill® , please write to: 

[email protected]

REFERENCES:
  1. Packer M, Lindstrom R, Thompson V, Parekh JG, Gupta P, Nijm LM, Donnenfeld E. Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye. J Cataract Refract Surg. 2024 Oct 1;50(10):1051-1057.
  2. Lacrifill. Instructions for use.

For use by European Healthcare professionals only

©2025 Nordic Pharma, All rights reserved. LACRIFILL® is a registered trademark of Nordic Pharma

GL-LAC-2500008 | October 2025

We use cookies and other similar technologies to improve your browsing experience and the functionality of our site. By clicking "Accept All Cookies," you consent to the storing on your device of all the technologies described in our Cookie Policy. You can revoke your cookie attestation by clearing your browser session and clicking "Dismiss".